# Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period

> **NCT01154491** · PHASE3 · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 303 (actual)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Erythropoietin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01154491
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154491, "Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01154491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*